NovaBay Pharmaceuticals Inc (NBY.A)

NBY.A on American Stock Exchange

0.67USD
19 Dec 2014
Price Change (% chg)

$0.04 (+6.35%)
Prev Close
$0.63
Open
$0.64
Day's High
$0.68
Day's Low
$0.63
Volume
53,088
Avg. Vol
34,620
52-wk High
$1.44
52-wk Low
$0.55

NBY.A

Chart for NBY.A

About

NovaBay Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on addressing the unmet therapeutic needs of the global anti-infective market. The Company’s Aganocide compounds, led by NVC-422, are patented, synthetic molecules with a spectrum of activity against bacteria, viruses and fungi. The Company is... (more)

Overall

Beta: 0.59
Market Cap (Mil.): $34.59
Shares Outstanding (Mil.): 51.63
Dividend: --
Yield (%): --

Financials

  NBY.A Industry Sector
P/E (TTM): -- 180.08 38.03
EPS (TTM): -0.32 -- --
ROI: -166.32 -0.62 18.26
ROE: -267.51 -1.77 19.16
Search Stocks

Competitors

  Price Change
PuriCore plc (PURI.L) 32.50p +1.12
C.R. Bard, Inc. (BCR.N) $169.50 -2.08
Smith & Nephew plc (SN.L) 1,089.00p +4.00
Abbott Laboratories (ABT.N) $46.05 +0.28
GlaxoSmithKline plc (GSK.L) 1,392.00p +13.50
3M Co (MMM.N) $165.48 +0.18
Sanofi SA (SASY.PA) €75.38 -0.79
Pfizer Inc. (PFE.N) $31.94 -0.03
Novartis AG (NOVN.VX) CHF93.05 +0.95
Johnson & Johnson (JNJ.N) $105.55 -1.26

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Wright Reports
$75.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks